Polaris Group (6550.TW)

TWD 43.8

(-3.74%)

Total Debt Summary of Polaris Group

  • Polaris Group's latest annual total debt in 2023 was 1.19 Billion TWD , up 213.11% from previous year.
  • Polaris Group's latest quarterly total debt in 2024 Q2 was 1.81 Billion TWD , up 49.66% from previous quarter.
  • Polaris Group reported annual total debt of 382.61 Million TWD in 2022, down -12.39% from previous year.
  • Polaris Group reported annual total debt of 436.75 Million TWD in 2021, up 34.14% from previous year.
  • Polaris Group reported quarterly total debt of 1.21 Billion TWD for 2024 Q1, up 1.26% from previous quarter.
  • Polaris Group reported quarterly total debt of 1.19 Billion TWD for 2023 Q4, up 19.93% from previous quarter.

Annual Total Debt Chart of Polaris Group (2023 - 2016)

Historical Annual Total Debt of Polaris Group (2023 - 2016)

Year Total Debt Total Debt Growth
2023 1.19 Billion TWD 213.11%
2022 382.61 Million TWD -12.39%
2021 436.75 Million TWD 34.14%
2020 325.58 Million TWD 17.93%
2019 276.08 Million TWD -73.31%
2018 1.03 Billion TWD 2.07%
2017 1.01 Billion TWD -33.25%
2016 1.51 Billion TWD 0.0%

Peer Total Debt Comparison of Polaris Group

Name Total Debt Total Debt Difference
Apex Biotechnology Corp. 180.83 Million TWD -562.515%
Sinphar Pharmaceutical Co.,Ltd. 1.94 Billion TWD 38.405%
Panion & Bf Biotech Inc. 727.83 Million TWD -64.603%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.2 Billion TWD 0.916%
GenMont Biotech Incorporation 58.3 Million TWD -1954.697%
Abnova (Taiwan) Corporation 7.7 Million TWD -15446.743%
Adimmune Corporation 3.14 Billion TWD 61.878%
Tanvex BioPharma, Inc. 1.73 Billion TWD 30.821%
Energenesis Biomedical CO.,LTD. - TWD -Infinity%
UnicoCell Biomed Co., Ltd. 74.32 Million TWD -1511.818%
PELL Bio-Med Technology Co. Ltd. 172.55 Million TWD -594.282%